European Crohn’s and Colitis Organisation
SubQ Guselkumab Found to Hit All Targets by 12 Weeks
Subcutaneous administration of guselkumab resulted in achievement of all study end points in people with moderate ...
JUNE 9, 2025
The Regueiro Report: From the Virtual ECCO 2020
Although these studies from the 2020 European Crohn’s and Colitis Organisation virtual meeting may be a bit ...
SEPTEMBER 7, 2020
Research Strengthens Role Of Environmental Factors in IBD Etiology
Recent data have bolstered the idea that the environment plays a key role in the development of inflammatory bowel ...
SEPTEMBER 4, 2020
Load more